New shot could ease psoriatic arthritis pain
NCT ID NCT07295509
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called picankibart for people with active psoriatic arthritis, a condition causing joint pain and skin plaques. About 222 adults will get either the drug or a placebo for 24 weeks to see if it improves joint swelling and tenderness. The goal is to find the best dose and confirm the drug's safety and effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIATIC ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new injection calm psoriatic arthritis?
- Can a once-daily pill tame psoriatic arthritis in everyday life?
- A single blood test may reveal whether a gene tied to transplant outcomes influences psoriatic arthritis risk.
- Can a 4-Minute chat rival a Dietitian's hour for heart health?
- Your plate may fight psoriatic arthritis: diet study tests food as medicine
- Real-World study tests whether aggressive early treatment improves psoriatic arthritis outcomes